The FCF Life Sciences IPO Report examines recent IPO trends in the Life Sciences sector, with a strong focus on the comparison of European and US characteristics.
LIFE SCIENCES RESEARCH SERIES
We constantly engage in capital markets research to identify financing trends early in the Life Sciences sector. Our FCF Life Sciences Research Series focuses on the most relevant equity markets: Venture Capital, Public Equity, Initial Public Offerings (IPO). The findings are currently published in the following publications:
Venture Capital Monitor
Monthly Venture capital activities in the European Life Sciences sector
Venture Capital ReportRecent Venture capital trends in the European Life Sciences sector
Public Equity MonitorRecent valuations of listed European Life Sciences companies
IPO ReportRecent IPO trends in the Life Sciences sector
NEWS & PRESS
FCF Life Sciences Venture Capital Monitor – 07/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – 07/2020”. The Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies,
FCF Life Sciences Venture Capital Monitor – 06/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – 06/2020”. The Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies,
FCF Life Sciences Public Equity Monitor 05/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Public Equity Monitor – 05/2020”. The Public Equity Monitor, part of FCF Life Sciences Research Series, is the most detailed and
New Partnership: FCF Life Sciences & YAFO Capital
FCF Fox Corporate Finance and YAFO Capital (Shanghai) announce Joint Venture Munich/Shanghai, June 17th, 2020 – The Life Sciences team at FCF Fox Corporate Finance is expanding its global network of strategic and capital investors
FCF Life Sciences Venture Capital Monitor – 05/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – 05/2020”. The Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies,
